Keyphrases
Erythroid
100%
Specific Expression
100%
Alternative Promoter
100%
Promoter Control
100%
Uroporphyrinogen III Synthase
100%
Exon
71%
Housekeeping
57%
Binding Site
42%
5′-untranslated Region (5′-UTR)
42%
Erythroid Cells
28%
GATA1
28%
TATA-less Promoter
28%
Complementary DNA (cDNA)
14%
Site-directed mutagenesis
14%
NIH3T3
14%
Erythroleukemia Cells
14%
Genome Sequencing
14%
Luciferase Activity
14%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
14%
Specific Promoter
14%
Luciferase
14%
Transcription Factor Sp1
14%
Reporter Construct
14%
K562 Cells
14%
Coding Exons
14%
Active-only
14%
Erythropoietic Protoporphyria
14%
OCT1
14%
Heme Biosynthesis Pathway
14%
Alternative Transcripts
14%
Pharmacology, Toxicology and Pharmaceutical Science
Binding Site
100%
Synthetase
100%
Uroporphyrinogen III Synthase
100%
Mouse
66%
Luciferase
66%
Transcription Factor GATA 1
66%
Complementary DNA
33%
Transcription Factor Sp1
33%
Mutagenesis
33%
Heme
33%
Erythroleukemia
33%
Congenital Erythropoietic Porphyria
33%
Biochemistry, Genetics and Molecular Biology
Promoter Region
100%
Uroporphyrinogen III Synthase
100%
Exon
85%
Binding Site
42%
Synthase
42%
Untranslated Region
42%
Enzyme
28%
Mouse
28%
Luciferase
28%
GATA1
28%
Enhancer Region
14%
Anabolism
14%
Wild Type
14%
Site-Directed Mutagenesis
14%
Porphyria
14%
Sp1 Transcription Factor
14%
K562 Cells
14%
Immunology and Microbiology
Promoter Region
100%
Exon
85%
Binding Site
42%
Untranslated Region
42%
Mouse
28%
Erythroid Cell
28%
Transcription Factor GATA 1
28%
Erythroleukemia Cell
14%
Wild Type
14%
Enhancer Region
14%
Site Directed Mutagenesis
14%
Cell Line
14%
Heme
14%
Transcription Factor Sp1
14%
Biosynthesis
14%